Amland Robert C, Haley James M, Lyons Jason J
Cerner Corporation, Kansas City, MO
Unity Hospital, Rochester, NY.
Am J Med Qual. 2016 Nov;31(6):501-508. doi: 10.1177/1062860615606801. Epub 2015 Oct 21.
Sepsis is an inflammatory response triggered by infection, with risk of in-hospital mortality fueled by disease progression. Early recognition and intervention by multidisciplinary sepsis programs may reverse the inflammatory response among at-risk patient populations, potentially improving outcomes. This retrospective study of a sepsis program enabled by a 2-stage sepsis Clinical Decision Support (CDS) system sought to evaluate the program's impact, identify early indicators that may influence outcomes, and uncover opportunities for quality improvement. Data encompassed 16 527 adult hospitalizations from 2014 and 2015. Of 2108 non-intensive care unit patients screened-in by sepsis CDS, 97% patients were stratified by 177 providers. Risk of adverse outcome improved 30% from baseline to year end, with gains materializing and stabilizing at month 7 after sepsis program go-live. Early indicators likely to influence outcomes include patient age, recent hospitalization, electrolyte abnormalities, hypovolemic shock, hypoxemia, patient location when sepsis CDS activated, and specific alert patterns.
脓毒症是一种由感染引发的炎症反应,疾病进展会加剧院内死亡风险。多学科脓毒症项目的早期识别和干预可能会逆转高危患者群体中的炎症反应,从而有可能改善治疗结果。这项对由两阶段脓毒症临床决策支持(CDS)系统促成的脓毒症项目的回顾性研究,旨在评估该项目的影响,识别可能影响治疗结果的早期指标,并发现质量改进的机会。数据涵盖了2014年和2015年的16527例成人住院病例。在脓毒症CDS筛查出的2108例非重症监护病房患者中,97%的患者由177名医护人员进行了分层。从基线到年底,不良结局风险改善了30%,在脓毒症项目启动后的第7个月,改善效果显现并趋于稳定。可能影响治疗结果的早期指标包括患者年龄、近期住院史、电解质异常、低血容量性休克、低氧血症、脓毒症CDS激活时患者所在位置以及特定警报模式。